![Alexia Perouse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexia Perouse
Direktor/Vorstandsmitglied bei SPINEGUARD
Aktive Positionen von Alexia Perouse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SPINEGUARD | Direktor/Vorstandsmitglied | 27.03.2009 | - |
Independent Dir/Board Member | 27.03.2009 | - | |
Chronolife SAS
![]() Chronolife SAS Miscellaneous Commercial ServicesCommercial Services Chronolife SAS engages in the research and development activity in natural sciences. The company is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - | - |
Cyann Holding
![]() Cyann Holding Financial ConglomeratesFinance Cyann Holding functions as an investment holding French company. | Vorsitzender | - | - |
iBionext SAS
![]() iBionext SAS Investment ManagersFinance iBionext SAS (iBionext) is an independent venture capital firm headquartered in Paris, France. The firm was founded in 2012 by Christophe Bancel and Alexia Perouse. | Vorstandsvorsitzender | 01.01.2015 | - |
Gründer | 01.01.2015 | - | |
T-Heart SAS
![]() T-Heart SAS Miscellaneous Commercial ServicesCommercial Services T-Heart SAS is an investment holding company with interest in research and development services on natural sciences sector. The company was founded on December 06, 2018 and is headquartered in Paris, France. | Vorsitzender | 08.12.2018 | - |
Karriereverlauf von Alexia Perouse
Ehemalige bekannte Positionen von Alexia Perouse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Omnes Capital SAS /Venture/
![]() Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Director of Investments | 25.03.2009 | 31.12.2015 |
Private Equity Investor | 01.01.2005 | 31.12.2015 | |
Corporate Officer/Principal | 01.01.2005 | 31.12.2015 | |
CELLNOVO | Direktor/Vorstandsmitglied | - | 11.09.2015 |
STENTYS | Direktor/Vorstandsmitglied | 20.11.2009 | 27.05.2014 |
Tilak Healthcare SAS
![]() Tilak Healthcare SAS Packaged SoftwareTechnology Services Tilak Healthcare SAS develops platform of serious medical games. It enables diagnostic and therapy of ophthalmologic diseases through early detection and self-tracking. The company was founded in 2016 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - | - |
░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░ ░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Statistik
International
Frankreich | 18 |
Vereinigte Staaten | 3 |
Belgien | 2 |
Operativ
Director/Board Member | 16 |
Chairman | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 13 |
Finance | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SPINEGUARD | Health Technology |
PIXIUM VISION | Health Technology |
Private Unternehmen | 18 |
---|---|
CircuLite, Inc.
![]() CircuLite, Inc. Medical DistributorsDistribution Services CircuLite, Inc. provided treatment for heart disorders. The company was founded by Paul J. Southworth and Paul Spence in November 2004 and was headquartered in Teaneck, NJ. | Distribution Services |
Mutabilis SA
![]() Mutabilis SA Pharmaceuticals: MajorHealth Technology Mutabilis SA specializes in the discovery and development of anti-infective drugs. It focuses on novel therapeutic approaches for controlling severe and nosocomial infections. The firm offers antibacterial, vaccines, anti-infective agents, gram-positive & negative ant virulence lead series, specific antigens, and screening technologies for antibacterial and virulence targets. The company was founded in 2001 by Xavier Nassif and is headquartered in Romainville, France. | Health Technology |
SuperSonic Imagine SA
![]() SuperSonic Imagine SA Medical SpecialtiesHealth Technology SuperSonic Imagine SA specializes in ultrasound medical imaging. The company designs, develops and markets a new generation ultrasound system, Aixplorer with an UltraFastTM platform that can acquire images faster than conventional ultrasound systems. Its products are used for general imaging, vascular, hepatology, gastroenterology, and research procedures. It operates under the Aixplorer trademark. SuperSonic Imagine was founded by Jacques Souquet, Armen Sarvazyan, Claude Cohen-Bacrie, Damien Dolimier, Georges Charpak, Jérémy Bercoff, Mickaël Tanter, Mathias Fink and Marianne Leven on March 10, 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Omnes Capital SAS /Venture/
![]() Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Finance |
Stentys SA
![]() Stentys SA Medical SpecialtiesHealth Technology Stentys SA engages in the design, development, and marketing of self-expanding stents used in treating cardiovascular diseases. It provides solutions for the treatment of acute myocardial infarction and other complex coronary diseases. Its products include Xposition S, Devoir, AmazoniaSir, stemiCath, Yangtzenano and YangtzeNC. The company was founded by Gonzague Issenmann and Jacques Seguin on July 6, 2006 and is headquartered in Neuilly-sur-Seine, France. | Health Technology |
EOS Imaging SA
![]() EOS Imaging SA Medical SpecialtiesHealth Technology EOS Imaging SA engages in the development and marketing of imaging and imaged-based solutions for diagnosing, treating, and monitoring common musculoskeletal pathologies. It operates through the France and North America geographical segments. The firm trademarks include EOSedge, sterEOS, spineEOS, hipEOS, and kneeEOS. The company was founded by Georges Charpak on February 8, 1989 and is headquartered in Paris, France. | Health Technology |
Eye Tech Care SA
![]() Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France. | Health Technology |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
ULURU Delaware, Inc.
![]() ULURU Delaware, Inc. BiotechnologyHealth Technology Part of ULURU, Inc., ULURU Delaware, Inc. develops drug delivery systems. The company is based in Virginia Beach, VA. The CEO of the company is R. Stephen Stagner. | Health Technology |
Amakem NV
![]() Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Health Services |
Tissium SA
![]() Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Health Technology |
iBionext SAS
![]() iBionext SAS Investment ManagersFinance iBionext SAS (iBionext) is an independent venture capital firm headquartered in Paris, France. The firm was founded in 2012 by Christophe Bancel and Alexia Perouse. | Finance |
Brainever SAS
![]() Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France. | Health Technology |
Chronolife SAS
![]() Chronolife SAS Miscellaneous Commercial ServicesCommercial Services Chronolife SAS engages in the research and development activity in natural sciences. The company is headquartered in Paris, France. | Commercial Services |
Tilak Healthcare SAS
![]() Tilak Healthcare SAS Packaged SoftwareTechnology Services Tilak Healthcare SAS develops platform of serious medical games. It enables diagnostic and therapy of ophthalmologic diseases through early detection and self-tracking. The company was founded in 2016 and is headquartered in Paris, France. | Technology Services |
Cyann Holding
![]() Cyann Holding Financial ConglomeratesFinance Cyann Holding functions as an investment holding French company. | Finance |
T-Heart SAS
![]() T-Heart SAS Miscellaneous Commercial ServicesCommercial Services T-Heart SAS is an investment holding company with interest in research and development services on natural sciences sector. The company was founded on December 06, 2018 and is headquartered in Paris, France. | Commercial Services |
Cellnovo Group SA
![]() Cellnovo Group SA Medical SpecialtiesHealth Technology Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Alexia Perouse
- Erfahrung